Bioscan Research has raised $1 million led by Unicorn India Ventures, with proceeds going to market expansion, further regulatory approvals, product upgrades and new intellectual property.
Valuation, dilution, instrument, co-investors, revenue and unit volumes were all left undisclosed.
CEREBO already holds CDSCO and DCGI clearance, was validated with AIIMS Bhopal and NIMHANS, and was recommended to state governments by the ICMR in August 2025, which is a genuine barrier to any ne…
The company's stated founding year and headquarters conflict with startup database records, and the 5x growth claim is published without a base figure, so neither can be read as a performance indic…
Read the full story on StartupFox